TELA Bio
TELA • NASDAQ
TELA Bio is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Antony Koblish, with a market cap of $30.0M.
CEOAntony Koblish
Next Earnings
Upcoming earnings announcement for TELA Bio
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.17
Revenue Estimate
$18.5M
Earnings History
Past 12 earnings reports for TELA Bio
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 24, 2026 | Q4 2025 | -$0.17Est: -$0.18 | +5.6% | $20.9MEst: $21.0M | -0.7% | — |
| Nov 13, 2025 | Q3 2025 | -$0.19Est: -$0.19 | 0.0% | $20.7MEst: $21.8M | -5.2% |  10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.22Est: -$0.18 | -22.2% | $20.2MEst: $20.6M | -2.1% | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.25Est: -$0.23 | -8.7% | $18.5MEst: $21.1M | -12.4% | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.23Est: -$0.22 | -4.5% | $17.6MEst: $23.2M | -23.8% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.42Est: -$0.40 | -5.0% | $19.0MEst: $18.9M | +0.6% | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.51Est: -$0.47 | -8.5% | $16.1MEst: $18.5M | -12.8% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.54Est: -$0.50 | -8.0% | $16.6MEst: $16.3M | +1.7% | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.53Est: -$0.43 | -23.3% | $17.0MEst: $16.4M | +3.7% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.45Est: -$0.49 | +8.2% | $15.1MEst: $16.2M | -7.1% | — |
| Aug 9, 2023 | Q2 2023 | -$0.46Est: -$0.53 | +13.2% | $14.5MEst: $14.4M | +0.7% | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.63Est: -$0.56 | -12.5% | $11.9MEst: $12.0M | -0.9% | 10-Q |